A. Heyll

3.1k total citations
65 papers, 1.7k citations indexed

About

A. Heyll is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, A. Heyll has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in A. Heyll's work include Acute Myeloid Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Multiple Myeloma Research and Treatments (9 papers). A. Heyll is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (19 papers) and Multiple Myeloma Research and Treatments (9 papers). A. Heyll collaborates with scholars based in Germany, Austria and South Korea. A. Heyll's co-authors include Norbert Gattermann, Wolfgang Schneider, C. Aul, Ulrich Germing, G. Derigs, Carlo Aul, C. Aul, Volker Runde, D. Söhngen and Ulrich Germing and has published in prestigious journals such as Blood, Cancer and Pain.

In The Last Decade

A. Heyll

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Heyll Germany 22 1.2k 412 371 336 331 65 1.7k
Ichiro Tsukimoto Japan 26 1.6k 1.3× 397 1.0× 320 0.9× 605 1.8× 519 1.6× 78 2.2k
Robert Hast Sweden 23 1.4k 1.2× 461 1.1× 587 1.6× 184 0.5× 345 1.0× 99 2.0k
H. L. Haak Netherlands 17 1.1k 0.9× 320 0.8× 534 1.4× 245 0.7× 283 0.9× 42 1.8k
Sucha Nand United States 22 814 0.7× 452 1.1× 339 0.9× 132 0.4× 199 0.6× 72 1.6k
Emmanuel Plouvier France 24 631 0.5× 368 0.9× 179 0.5× 373 1.1× 446 1.3× 63 2.0k
H. Clark Hoagland United States 18 721 0.6× 304 0.7× 374 1.0× 124 0.4× 259 0.8× 38 1.6k
Ashwin Kashyap United States 11 1.2k 1.0× 157 0.4× 272 0.7× 355 1.1× 530 1.6× 13 1.8k
Riccardo Ghio Italy 20 630 0.5× 226 0.5× 286 0.8× 90 0.3× 273 0.8× 93 1.2k
Ólafur G. Jónsson Denmark 26 1.2k 1.0× 262 0.6× 129 0.3× 967 2.9× 326 1.0× 65 2.0k
Valéria Buccheri Brazil 18 471 0.4× 216 0.5× 234 0.6× 321 1.0× 204 0.6× 59 1.2k

Countries citing papers authored by A. Heyll

Since Specialization
Citations

This map shows the geographic impact of A. Heyll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Heyll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Heyll more than expected).

Fields of papers citing papers by A. Heyll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Heyll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Heyll. The network helps show where A. Heyll may publish in the future.

Co-authorship network of co-authors of A. Heyll

This figure shows the co-authorship network connecting the top 25 collaborators of A. Heyll. A scholar is included among the top collaborators of A. Heyll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Heyll. A. Heyll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aul, C., Ulrich Germing, Norbert Gattermann, D. Söhngen, & A. Heyll. (2008). Prognostische Bedeutung der Serum-Thymidinkinase beim myelodysplastischen Syndrom. DMW - Deutsche Medizinische Wochenschrift. 121(37). 1113–1118. 1 indexed citations
2.
Aul, Carlo & A. Heyll. (2008). Therapie der myelodysplastischen Syndrome. DMW - Deutsche Medizinische Wochenschrift. 115(48). 1842–1850.
3.
Giagounidis, Aristoteles, Matthias W. Beckmann, Manuel Aivado, et al.. (2000). Acute promyelocytic leukemia and pregnancy. European Journal Of Haematology. 64(4). 267–271. 28 indexed citations
4.
Burdach, Stefan, H.‐J. Laws, S. Ahrens, et al.. (2000). Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. Annals of Oncology. 11(11). 1451–1462. 106 indexed citations
5.
Hetzel, Gerd R., Philipp Schneider, Adrian Mondry, et al.. (2000). Therapieoptionen bei systemischer AL-Amyloidose mit Nierenbeteiligung. DMW - Deutsche Medizinische Wochenschrift. 125(34/35). 997–1002. 2 indexed citations
6.
Heyll, A., Ulrich Germing, A. Wehmeier, et al.. (1998). Dyshematopoiesis in De Novo Acute Myeloid Leukemia: Cell Biological Features and Prognostic Significance. Leukemia & lymphoma. 29(5-6). 523–531. 5 indexed citations
7.
Motherby, Helma, Ulrich Germing, A. Heyll, et al.. (1998). Pleural carcinosis confirmed by adjuvant cytological methods: A case report. Diagnostic Cytopathology. 19(5). 370–374. 1 indexed citations
9.
Germing, Ulrich, et al.. (1998). Problems in the classification of CMML—dysplastic versus proliferative type. Leukemia Research. 22(10). 871–878. 111 indexed citations
10.
Zucker, Tom-Philipp, et al.. (1998). Patient-controlled versus staff-controlled analgesia with pethidine after allogeneic bone marrow transplantation. Pain. 75(2). 305–312. 16 indexed citations
11.
Südhoff, Thomas, Michael Heins, D. Söhngen, et al.. (1998). Plasma levels of D‐dimer and circulating endothelial adhesion molecules in veno‐occlusive disease of the liver following allogeneic bone marrow transplantation. European Journal Of Haematology. 60(2). 106–111. 8 indexed citations
12.
Kobbe, Guido, et al.. (1997). Large Volume Leukapheresis Maximizes the Progenitor Cell Yield for Allogeneic Peripheral Blood Progenitor Donation. Journal of Hematotherapy. 6(2). 125–131. 26 indexed citations
13.
Heyll, A., D. Söhngen, Guido Kobbe, et al.. (1997). Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients.. PubMed. 11 Suppl 5. S32–4. 7 indexed citations
14.
Stege, H., et al.. (1997). Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. Journal of the American Academy of Dermatology. 36(5). 787–789. 29 indexed citations
15.
Aul, Carlo, Norbert Gattermann, Ulrich Germing, et al.. (1997). Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia. Leukemia Research. 21(3). 249–253. 11 indexed citations
16.
Heyll, A., Carlo Aul, Volker Runde, et al.. (1994). Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia. Annals of Hematology. 68(6). 279–283. 14 indexed citations
17.
Aul, Carlo, Norbert Gattermann, Ulrich Germing, et al.. (1994). Serum deoxythymidine kinase in myelodysplastic syndromes. Cancer. 73(2). 322–327. 7 indexed citations
18.
Heyll, A., C. Aul, Michael J. Thomas, et al.. (1991). Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates. Annals of Hematology. 63(6). 328–332. 12 indexed citations
19.
Heyll, A. & G. Derigs. (1990). Chronic Myelomonocytic Leukemia: Clinical Data, Morphological Features, and Outcome in 56 Patients. Hämatologie und Bluttransfusion. 33. 387–391. 4 indexed citations
20.
Arning, M., et al.. (1990). Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin. Journal of Antimicrobial Chemotherapy. 26(suppl D). 137–142. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026